Microbix Biosystems Inc. MBX

Updated: 12 Jun 2026

TSX | Biotech | Diagnostics and biological products

No signal published yet

We already track Microbix Biosystems and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Microbix Biosystems free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
TSX
Type
Biotech
Sector
Diagnostics and biological products
We're already tracking Microbix Biosystems Inc. — here are the latest events we've registered

Recent News

  • On May 14, 2026, Microbix reported second-quarter fiscal 2026 revenue of $3.38 million CAD, a decrease primarily caused by lower antigen sales in China. The company maintained a cash position of $8.1 million CAD and noted that sales to antigen customers outside of China grew by 13%.

What Firelda Watch includes for Microbix Biosystems Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Microbix Biosystems Inc. will be delivered in the same format.

Want to follow Microbix Biosystems Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Microbix Biosystems free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Microbix Biosystems Inc. MBX
Microbix Biosystems — follow and we'll monitor it
Follow Microbix Biosystems free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.